From: Post-resuscitation shock: recent advances in pathophysiology and treatment
Scores | Points | |||
---|---|---|---|---|
Assessment of risk of circulatory-related death | ||||
CREST score | ||||
History of coronary artery disease | 1 | |||
Non-shockable rhythm | 1 | |||
LVEF at time of admission < 30% | 1 | |||
Shock at presentation | 1 | |||
Ischemic time > 25 min | 1 | |||
Assessment of neurological prognosis | ||||
CAHP score | ||||
Age | 1.1 × (age − 10) | |||
Setting | 0 if public setting and 24 if home | |||
Initial Rhythm | 0 if shockable and 27 if non-shockable | |||
Collapse-BLS duration (min) | 2.8 × duration | |||
BLS-ROSC duration (min) | 0.8 × duration | |||
pH | 585–77 × pH | |||
Epinephrine dose during ressuscitation (total) | 0 if 0 mg and 27 if 1 or 2 mg | |||
OHCA score | ||||
Ventricular fibrillation or tachycardia |
− 13 if the initial recorded rhythm is VF or ventricular tachycardia + 6 × ln (no-flow interval) + 9 × ln (low-flow interval) − 1434/serum creatinine + 10 × ln (arterial lactate) | |||
No-flow interval (min) | ||||
Low-flow interval (min) | ||||
Serum creatinine (µmol/L) | ||||
Lactate (mmol/L) | ||||
CAST score | ||||
0 | 1 | 2 | 3 | |
Initial rhythm | Shockable | Non-shockable | – | – |
Witness/ROSC time (min) | < 20 min | ≥ 20 min | No witness | – |
pH | ≥ 7.31 | 7.16–7.30 | 7.01–7.15 | ≤ 7.00 |
Lactate (mmol/L) | ≤ 5.0 | 5.1–10.0 | 10.1–14.0 | ≥ 14.1 |
Motor component of Glasgow coma scale | ≥ 2 | 1 | – | – |
Gray matter attenuation to white matter attenuation ratio | ≥ 1.201 | 1.151–1.200 | ≤ 1.150 | – |
Albumin (g/dL) | ≥ 3.6 | 3.1–3.5 | ≤ 3.0 | – |
Hemoglobin (g/dL) | ≥ 13.1 | 11.1–13.0 | ≤ 11.0 |